CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
2 research outputs found
Management of common adverse events related to first-line dacomitinib use in EGFR
Author
Diana Gernhardt
Edward B Garon
+9Â more
Eric I Sbar
Jesus Corral
Kay Noonan
Kazuhiko Nakagawa
Qing Zhou
Rickard Sandin
Tao Wang
Tony S Mok
Yi-Long Wu
Publication venue
'Future Medicine Ltd'
Publication date
Field of study
No full text
Crossref
Dacomitinib (daco) versus gefitinib (gef) for first-line treatment of advanced NSCLC (ARCHER 1050): Final overall survival (OS) analysis.
Author
Adam Pluzanski
Eric I Sbar
+14Â more
Jane Liang White
Jesus Corral Jaime
Kazuhiko Nakagawa
Ki Hyeong Lee
Maria Rita Migliorino
Min Young Lee
Rafael Rosell
Rolf Gerhard Linke
Seiji Niho
Tao Wang
Tony Mok
Xiangdong Zhou
Yi-Long Wu
Ying Cheng
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref